Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results

Background: To evaluate outcomes in terms of survival and toxicity in a series of intermediate-risk prostate cancer (PCa) patients treated with hypofractionated radiotherapy (HyRT) + hormonal therapy (HT) with or without image guidance (IGRT) and to investigate the impact of different variables. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Valeriani, Maurizio, Di Staso, Mario, Facondo, Giuseppe, Vullo, Gianluca, De Sanctis, Vitaliana, Gravina, Giovanni Luca, di Genesio Pagliuca, Milena, Osti, Mattia Falchetto, Bonfili, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410091/
https://www.ncbi.nlm.nih.gov/pubmed/36013023
http://dx.doi.org/10.3390/jcm11164783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410091/
https://www.ncbi.nlm.nih.gov/pubmed/36013023
http://dx.doi.org/10.3390/jcm11164783

Ejemplares similares